Quarterly ResultMar 30, 2026, 04:13 AM
Amgen Reports Q3 2025 Results: Revenue Up 12% to $9.6 Billion, GAAP EPS Up 14%
AI Summary
Amgen announced its Q3 2025 financial results, reporting a 12% increase in total revenue to $9.6 billion compared to Q3 2024. GAAP earnings per share increased by 14% to $5.93, driven by higher revenues, partially offset by higher operating expenses, including an Otezla intangible asset impairment charge of $400 million.
Key Highlights
- Total revenues increased 12% to $9.6 billion.
- GAAP EPS increased 14% to $5.93.
- Non-GAAP EPS increased 1% to $5.64.
- Free cash flow generated was $4.2 billion, compared to $3.3 billion in Q3 2024.
- Otezla intangible asset impairment charge of $400 million recorded.
Price Impact
More from AMGN